Thomas Struengmann & family
Overview
- Source of Wealth
- Pharmaceuticals
- Industry
- Healthcare
- Residence
- Tegernsee
- Education
- University of Augsburg (Master of Business Administration)University of Augsburg (Master of Business Administration)
- Marital Status
- Married
- Children
- 4
Assets
- BioNTech Sponsored ADR50,640,000 shares @ --BNTX-US
- Formycon AG2,124,000 shares @ --FYB-DE
Biography
Thomas Struengmann and twin brother Andreas were early backers of German firm BioNTech, which partnered with Pfizer to make a vaccine for Covid-19.
The brothers cofounded generic drugmaker Hexal in 1986 and sold it to Novartis in 2005 for some $7 billion.
The brothers invest in biotech, pharma, life sciences and healthcare companies through their Zug, Switzerland-based investment firm, Santo Holding.
In 2008, they established a neuroscience research center in Frankfurt named after their father, Ernst Struengmann.
About
After obtaining a business degree from the University of Augsburg, Thomas worked as a marketing manager for Schering-Plough.
Like his brother, an identical twin, he is said to be an accomplished golfer and likes to ski. He reportedly collects modern art and Swiss watches.